[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343186-105":59,"doc-detail-343186-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","obesity-associated-colorectal-cancer-review","Obesity-Associated Colorectal Cancer - Review","","Colorectal cancer (CRC) affects about 2 million people worldwide, with obesity acting as a major risk factor. Obesity promotes a chronic inflammatory state that drives tumor progression through proinflammatory cytokine secretion and adds molecular alterations linked to cancer hallmarks, including genome instability, sustained proliferation, telomere dysfunction, angiogenesis, and microbiome changes. Evidence to date shows that therapies for obesity-associated CRC generally mirror standard treatments for normal-weight patients. This review consolidates knowledge on epidemiology, risk factors, molecular mechanisms, and current treatments, and highlights potential new therapeutic targets. Reversing obesity is proposed as a strategy to improve antineoplastic CRC outcomes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/obesity-associated-colorectal-cancer-review/343186/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/obesity-associated-colorectal-cancer-review/343186.png","ImageObject",300,407,{"name":92,"@type":93},"Theodore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does obesity increase the risk and progression of colorectal cancer?","Question",{"text":112,"@type":113},"Obesity is a major CRC risk factor and contributes to a chronic inflammatory stage. It enhances tumor progression via proinflammatory cytokine secretion and is associated with molecular changes tied to cancer characteristics.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Do obesity-associated CRC treatments differ from standard CRC treatments?",{"text":117,"@type":113},"Despite accumulating evidence, treatments for obesity-associated CRC do not differ from those used for CRC in normal-weight individuals, according to the review’s summary.",{"name":119,"@type":110,"acceptedAnswer":120},"What areas does the review cover and what does it suggest for future therapy?",{"text":121,"@type":113},"The review summarizes epidemiology, risk factors, molecular factors, and current treatments for obesity-associated cancer. It also enumerates possible new therapeutic targets and suggests reversing obesity to improve antineoplastic CRC outcomes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},343186,1790275243,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":24,"preview_urls":146},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Review  \nObesity-Associated Colorectal Cancer  \nLucia Gonzalez-Gutierrez 1, Omar Motiño 1, Daniel Barriuso 1, Juan de la Puente-Aldea 1,  \nLucia Alvarez-Frutos 1, Guido Kroemer 2,3,4, Roberto Palacios-Ramirez 1,† and Laura Senovilla 1,2,3, *,†  \nCitation: Gonzalez-Gutierrez, L.; Motiño, O.; Barriuso, D.; de la Puente-Aldea, J.; Alvarez-Frutos, L.; Kroemer, G.; Palacios-Ramirez, R.; Senovilla, L. Obesity-Associated Colorectal Cancer. Int. J. Mol. Sci. 2024, 25, 8836. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/ijms25168836](10.3390/ijms25168836)  \nAcademic Editor: Cristina Peña  \nReceived: 12 July 2024  \nRevised: 2 August 2024  \nAccepted: 7 August 2024  \nPublished: 14 August 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Unidad de Excelencia Instituto de Biología y Genética Molecular (IBGM), Universidad de Valladolid–CSIC, 47003 Valladolid, Spain; [lucia.gonzalezg@uva.es](lucia.gonzalezg@uva.es) (L.G.-G.); [omar.motino@uva.es](omar.motino@uva.es) (O.M.); [daniel.barriuso@uva.es](daniel.barriuso@uva.es) (D.B.); [jpualdea@gmail.com](jpualdea@gmail.com) (J.d.l.P.-A.); [lucia.alvarez.frutos@uva.es](lucia.alvarez.frutos@uva.es) (L.A.-F.); [roberto.palacios@uva.es](roberto.palacios@uva.es) (R.P.-R.)  \n2 Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, 75006 Paris, France; [kroemer@orange.fr](kroemer@orange.fr)  \n3 Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, 94805 Villejuif, France  \n4 Institut du Cancer Paris CARPEM, Department of Biology, Hôpital Européen Georges Pompidou, AP-HP, 75015 Paris, France  \n* Correspondence: [laurasenovilla@hotmail.com](laurasenovilla@hotmail.com)  \n† These authors share co-senior authorship.  \nAbstract: Colorectal cancer (CRC) affects approximately 2 million people worldwide. Obesity is the major risk factor for CRC. In addition, obesity contributes to a chronic inflammatory stage that enhances tumor progression through the secretion of proinflammatory cytokines. In addition to an increased inflammatory response, obesity-associated cancer presents accrued molecular factors related to cancer characteristics, such as genome instability, sustained cell proliferation, telomere dysfunctions, angiogenesis, and microbial alteration, among others. Despite the evidence accumulated over the last few years, the treatments for obesity-associated CRC do not differ from the CRC treatments in normal-weight individuals. In this review, we summarize the current knowledge on obesity-associated cancer, including its epidemiology, risk factors, molecular factors, and current treatments. Finally, we enumerate possible new therapeutic targets that may improve the conditions of obese CRC patients. Obesity is key for the development of CRC, and treatments resulting in the reversal of obesity should be considered as a strategy for improving antineoplastic CRC therapies.  \nKeywords: colorectal cancer; obesity; epidemiology; risk factors; molecular factors; treatments; targets  \n1. Introduction  \nColorectal cancer (CRC) affects approximately 2 million people and is the second leading cause of mortality worldwide, accounting for 9.3%(~900,000 deaths) . Although the incidence of CRC has increased by 70% since the 1990s, the 5-year mortality and prevalence rates have decreased because of early detection, prevention, and new therapies. Currently, the 5-year and 10-year survival rates are 65% and 58%, respectively. However, the International Agency for Research on Cancer (IARC) projects a 56% increase in CRC by 2040 [1,2] . Certain factors, such as ag","cbCaicFXO9YO6hR4","https://ap.wps.com/l/cbCaicFXO9YO6hR4","pdf",2422286,45,"English","# Introduction\n## Obesity and CRC risk overview\n# Abstract\n# Keywords","[{\"question\":\"How does obesity increase the risk and progression of colorectal cancer?\",\"answer\":\"Obesity is a major CRC risk factor and contributes to a chronic inflammatory stage. It enhances tumor progression via proinflammatory cytokine secretion and is associated with molecular changes tied to cancer characteristics.\"},{\"question\":\"Do obesity-associated CRC treatments differ from standard CRC treatments?\",\"answer\":\"Despite accumulating evidence, treatments for obesity-associated CRC do not differ from those used for CRC in normal-weight individuals, according to the review’s summary.\"},{\"question\":\"What areas does the review cover and what does it suggest for future therapy?\",\"answer\":\"The review summarizes epidemiology, risk factors, molecular factors, and current treatments for obesity-associated cancer. It also enumerates possible new therapeutic targets and suggests reversing obesity to improve antineoplastic CRC outcomes.\"}]","Obesity-Associated Colorectal Cancer - Review | PDF",1790050207,113,[147,151,155,159,163],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b5fdf66d0fecb07b035c7b6694305339.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c2c50530e04c2a07622a4c05b87290d1.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ee2b24f48fe6966f3ad9b48a5b392c50.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/30956f00041c26f19813a4d048f90047.webp",980,1385,{"page_no":24,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9981c5115b40da3bde5068e46091121b.webp",979,1384]